Functional Gastroduodenal Disorders

Talley, 1999, Functional gastroduodenal disorders, Gut, 45, 37 Stanghellini, 2001, Review article, Aliment Pharmacol Ther, 15, 145, 10.1046/j.1365-2036.2001.00906.x Colin-Jones, 1988, Management of dyspepsia, Lancet, 1, 576 Talley, 1993, Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy, Gastroenterology, 105, 1378, 10.1016/0016-5085(93)90142-Y Klauser, 1990, Symptoms in gastro-esophageal reflux disease, Lancet, 335, 205, 10.1016/0140-6736(90)90287-F Talley, 1992, Dyspepsia and dyspepsia subgroups, Gastroenterology, 102, 1259, 10.1016/0016-5085(92)90764-P Agreus, 1995, Irritable bowel syndrome and dyspepsia in the general population, Gastroenterology, 109, 671, 10.1016/0016-5085(95)90373-9 Johnsen, 1991, Prevalence of endoscopic and histological findings in subjects with and without dyspepsia, BMJ, 302, 749, 10.1136/bmj.302.6779.749 Klauser, 1993, What is behind dyspepsia?, Dig Dis Sci, 38, 147, 10.1007/BF01296788 Talley, 1992, Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders, Am J Epidemiol, 136, 165, 10.1093/oxfordjournals.aje.a116483 Talley, 1987, Prognosis of chronic unexplained dyspepsia. A prospective study of potential predictor variables in patients with endoscopically diagnosed nonulcer dyspepsia, Gastroenterology, 92, 1060, 10.1016/0016-5085(87)90983-8 Koloski, 2001, Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia, Am J Gastroenterol, 96, 1340, 10.1111/j.1572-0241.2001.03789.x Talley, 1998, Dyspepsia and health care seeking in a community, Dig Dis Sci, 43, 1016, 10.1023/A:1018878717715 Drossman, 1990, Identification of subgroups of functional gastrointestinal disorders, Gastroenterol Int, 3, 159 Stanghellini, 1999, Predominant symptoms identify different subgroups in functional dyspepsia, Am J Gastroenterol, 94, 2080, 10.1111/j.1572-0241.1999.01281.x Laheij, 2004, Predominant symptom behavior in patients with persistent dyspepsia during treatment, J Clin Gastroenterol, 38, 490, 10.1097/01.mcg.0000123164.86324.24 Stanghellini, 1996, Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia, Gastroenterology, 110, 1036, 10.1053/gast.1996.v110.pm8612991 Perri, 1998, Patterns of symptoms in functional dyspepsia, Am J Gastroenterol, 93, 2082, 10.1111/j.1572-0241.1998.00597.x Sarnelli, 2003, Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia, Am J Gastroenterol, 98, 783, 10.1111/j.1572-0241.2003.07389.x Tack, 1998, Role of impaired gastric accommodation to a meal in functional dyspepsia, Gastroenterology, 115, 1346, 10.1016/S0016-5085(98)70012-5 Tack, 2001, Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia, Gastroenterology, 121, 526, 10.1053/gast.2001.27180 Boeckxstaens, 2002, The proximal stomach and postprandial symptoms in functional dyspeptics, Am J Gastroenterol, 97, 40, 10.1111/j.1572-0241.2002.05421.x Rhee, 2000, Evaluation of individual symptoms cannot predict presence of gastric hypersensitivity in functional dyspepsia, Dig Dis Sci, 45, 1680, 10.1023/A:1005550019308 Talley, 2001, Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia?, Am J Gastroenterol, 96, 1422, 10.1111/j.1572-0241.2001.03683.x Peura, 2004, Lansoprazole in the treatment of functional dyspepsia, Am J Med, 116, 740, 10.1016/j.amjmed.2004.01.008 Tack, 2005, Prevalence and symptomatic impact of non-erosive reflux disease in functional dyspepsia, Gut, 54, 1370, 10.1136/gut.2004.053355 Carlsson, 1998, The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease, Scand J Gastroenterol, 33, 1023, 10.1080/003655298750026697 Moayyedi, 2004, The efficacy of proton pump inhibitors in nonulcer dyspepsia, Gastroenterology, 127, 1329, 10.1053/j.gastro.2004.08.026 Thomson, 2003, The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia, Aliment Pharmacol Ther, 17, 1481, 10.1046/j.1365-2036.2003.01646.x Corsetti, 2004, Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia, Am J Gastroenterol, 99, 1152, 10.1111/j.1572-0241.2004.30040.x Talley, 1998, Efficacy of omeprazole in functional dyspepsia, Aliment Pharmacol Ther, 12, 1055, 10.1046/j.1365-2036.1998.00410.x Tack, 2004, Pathophysiology and treatment of functional dyspepsia, Gastroenterology, 127, 1239, 10.1053/j.gastro.2004.05.030 Westbrook, 2002, Empiric clustering of dyspepsia into symptom subgroups, Scand J Gastroenterol, 37, 917, 10.1080/003655202760230874 Fischler, 2003, Evidence-based subtypes in functional dyspepsia with confirmatory factor analysis, Gastroenterology, 124, 903, 10.1053/gast.2003.50155 Kwan, 2003, Validation of Rome II criteria for functional gastrointestinal disorders by factor analysis of symptoms in Asian patient sample, J Gastroenterol Hepatol, 18, 796, 10.1046/j.1440-1746.2003.03081.x Whitehead, 2003, Factor analyisis of bowel symptoms in US and Italian populations, Dig Liv Dis, 35, 774, 10.1016/S1590-8658(03)00456-0 Camilleri, 2005, Results from the US upper gastrointestinal study, Clin Gastroenterol Hepatol, 3, 543, 10.1016/S1542-3565(05)00153-9 Plessevaux, 2004, Heterogeneity of dyspepsia in the general population in Belgium, Gastroenterology, 126, A440 Tack, 2003, Association of weight loss with gastrointestinal symptoms in a tertiary-referred patient population (abstr), Gastroenterology, 124, A396, 10.1016/S0016-5085(03)82003-6 Jones, 2003, Clustering of weight loss with symptoms of functional dyspepsia, Gastroenterology, 124, A390, 10.1016/S0016-5085(03)81976-5 Talley, 2000, Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying, Aliment Pharmacol Ther, 14, 1653, 10.1046/j.1365-2036.2000.00868.x Talley, 2001, A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia, Aliment Pharmacol Ther, 15, 525, 10.1046/j.1365-2036.2001.00941.x Tack, 2002, A phase II placebo controlled randomized trial with tegaserod (T) in functional dyspepsia (FD) patients with normal gastric emptying (NGE), Gastroenterology, 122, 154 Castillo, 2004, A community-based, controlled study of the epidemiology and pathophysiology of dyspepsia, Clin Gastroenterol Hepatol, 2, 985, 10.1016/S1542-3565(04)00454-9 Veldhuyzen van Zanten, 2000, An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori, CMAJ, 162, S3 Hammer, 2004, Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia, Gut, 53, 666, 10.1136/gut.2003.021857 Straus, 2002, Do NSAIDs cause dyspepsia? A meta-analysis evaluating alternative dyspepsia definitions, Am J Gastroenterol, 97, 1951, 10.1111/j.1572-0241.2002.05905.x Manes, 2003, Empirical prescribing for dyspepsia, BMJ, 326, 1118, 10.1136/bmj.326.7399.1118 Arents, 2003, Approach to treatment of dyspepsia in primary care, Arch Intern Med, 163, 1606, 10.1001/archinte.163.13.1606 Lassen, 2000, Helicobacter pylori test-and-eradicate versus prompt endoscopy for management of dyspeptic patients, Lancet, 356, 455, 10.1016/S0140-6736(00)02553-8 McColl, 2002, Randomised trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H pylori testing alone in the management of dyspepsia, BMJ, 324, 99, 10.1136/bmj.324.7344.999 Talley, 2005, Guidelines for the management of dyspepsia, Am J Gastroenterol, 100, 2324, 10.1111/j.1572-0241.2005.00225.x Moayyedi, 2005, Eradication of Helicobacter pylori for non-ulcer dyspepsia, Cochrane Database Sys Rev, CD002096 Moayyedi, 2000, Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community, Lancet, 355, 1665, 10.1016/S0140-6736(00)02236-4 Delaney, 2000, Cost effectiveness of initial endoscopy for dyspepsia in patients over age 50 years, Lancet, 356, 1965, 10.1016/S0140-6736(00)03308-0 Delaney, 2001, Randomised controlled trial of Helicobacter pylori testing and endoscopy for dyspepsia in primary care, BMJ, 322, 898, 10.1136/bmj.322.7291.898 Malfertheiner, 2002, Current concepts in the management of Helicobacter pylori infection—The Maastricht 2-2000 Consensus Report, Aliment Pharmacol Ther, 16, 167, 10.1046/j.1365-2036.2002.01169.x Berger, 2000, Abdominal symptoms: do they predict gallstones? A systematic review, Scand J Gastroenterol, 35, 70, 10.1080/003655200750024560 Cuperus, 1996, Eating patterns in functional dyspepsia, Eur J Clin Nutr, 50, 520 Talley, 1994, Smoking, alcohol, and nonsteroidal anti-inflammatory drugs in outpatients with functional dyspepsia and among dyspepsia subgroups, Am J Gastroenterol, 89, 524 Holtmann, 2002, Do changes in visceral sensory function determine the development of dyspepsia during treatment with aspirin?, Gastroenterology, 123, 1451, 10.1053/gast.2002.36556 Collen, 1989, Basal gastric acid secretion in nonulcer dyspepsia with or without duodenitis, Dig Dis Sci, 34, 246, 10.1007/BF01536059 Sarnelli, 2003, Symptom patterns and pathophysiological mechanisms in dyspeptic patients with and without Helicobacter pylori, Dig Dis Sci, 48, 2229, 10.1023/B:DDAS.0000007856.71462.6c Greydanus, 1991, Neurohormonal factors in functional dyspepsia, Gastroenterology, 100, 1311, 10.1016/0016-5085(91)70018-S Wilmer, 1998, Ambulatory gastrojejunal manometry in severe motility-like dyspepsia, Gut, 42, 235, 10.1136/gut.42.2.235 Schwartz, 2001, Chemospecific alterations in duodenal perception and motor responses in functional dyspepsia, Am J Gastroenterol, 96, 2596, 10.1111/j.1572-0241.2001.04103.x Simren, 2003, Unsuppressed postprandial phasic contractility in the proximal stomach in functional dyspepsia, Am J Gastroenterol, 98, 2169 Jebbink, 1995, Gastric myoelectrical activity and gastrointestinal motility in patients with functional dyspepsia, Eur J Clin Invest, 25, 429, 10.1111/j.1365-2362.1995.tb01725.x Mearin, 1991, The origin of symptoms on the brain-gut axis in functional dyspepsia, Gastroenterology, 101, 999, 10.1016/0016-5085(91)90726-2 Ladabaum, 2001, Gastric distention correlates with activation of multiple cortical and subcortical regions, Gastroenterology, 120, 369, 10.1053/gast.2001.21201 Vandenberghe, 2005, Regional brain activation during proximal stomach distention in man, Gastroenterology, 128, 564, 10.1053/j.gastro.2004.11.054 Holtmann, 1998, Altered vagal and intestinal mechanosensory function in chronic unexplained dyspepsia, Gut, 15, 501, 10.1136/gut.42.4.501 Samsom, 1999, Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in patients with functional dyspepsia, Gastroenterology, 15, 515, 10.1016/S0016-5085(99)70171-X Feinle, 2001, Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia, Gut, 48, 347, 10.1136/gut.48.3.347 Lee, 2004, A pilot study on duodenal acid exposure and its relationship to symptoms in functional dyspepsia with prominent nausea, Am J Gastroenterol, 99, 1765, 10.1111/j.1572-0241.2004.30822.x Tougas, 2000, The autonomic nervous system in functional bowel disorders, Gut, 47, iv78 Holtmann, 2004, G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia, Gastroenterology, 126, 971, 10.1053/j.gastro.2004.01.006 Wilhelmsen, 1995, Discriminant analysis of factors distinguishing patients with functional dyspepsia from patients with duodenal ulcer. Significance of somatization, Dig Dis Sci, 40, 1105, 10.1007/BF02064207 Cheng, 2000, Seeking medical consultation, Psychosom Med, 62, 844, 10.1097/00006842-200011000-00015 Veldhuyzen van Zanten, 1996, Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for the design of future trials: report of an international working party, Am J Gastroenterol, 91, 660 Nyren, 1986, Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia, N Engl J Med, 314, 339, 10.1056/NEJM198602063140603 Moayyedi, 2003, Pharmacological interventions for non-ulcer dyspepsia, Cochrane Database Syst Rev, CD001960 Moayyedi, 2004, The efficacy of proton pump inhibitors in nonulcer dyspepsia, Gastroenterology, 127, 1329, 10.1053/j.gastro.2004.08.026 Veldhuyzen van Zanten, 2001, Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia, Am J Gastroenterol, 96, 689, 10.1016/S0002-9270(00)02314-5 Janssens, 1990, Improvement of gastric emptying in diabetic gastroparesis by erythromycin, N Engl J Med, 322, 1028, 10.1056/NEJM199004123221502 Richards, 1993, The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin, Am J Gastroenterol, 88, 203 Tack, 2004, Proximal gastric dysfunction in functional dyspepsia, Curr Treat Options Gastroenterol, 7, 265, 10.1007/s11938-004-0012-6 Halder, 2005, Treatment of functional dyspepsia, Curr Treat Options Gastroenterol, 8, 325, 10.1007/s11938-005-0026-8 Maxton, 1996, Selective 5-hydroxytryptamine antagonism, Aliment Pharmacol Ther, 10, 595, 10.1046/j.1365-2036.1996.30172000.x Mertz, 1998, Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia, Am J Gastroenterol, 93, 160, 10.1111/j.1572-0241.1998.00160.x Hamilton, 2000, A randomized controlled trial of psychotherapy in patients with chronic functional dyspepsia, Gastroenterology, 119, 661, 10.1053/gast.2000.16493 Calvert, 2002, Long-term improvement in functional dyspepsia using hypnotherapy, Gastroenterology, 123, 1778, 10.1053/gast.2002.37071 Sifrim, 1999, Patterns of gas and liquid reflux during transient lower oesophageal sphincter relaxation, Gut, 44, 47, 10.1136/gut.44.1.47 Bredenoord, 2004, Aerophagia, gastric, and supragastric belching, Gut, 53, 1561, 10.1136/gut.2004.042945 Lin, 2003, Belching, Am J Gastroenterol, 98, 2139, 10.1111/j.1572-0241.2003.07627.x Prakash, 2001, Similarities in cyclic vomiting syndrome across age groups, Am J Gastroenterol, 96, 684, 10.1111/j.1572-0241.2001.03606.x Prakash, 1999, Cyclic vomiting syndrome in adults, Am J Gastroenterol, 94, 2855, 10.1111/j.1572-0241.1999.01428.x Muraoka, 1990, Psychogenic vomiting, Gut, 31, 526, 10.1136/gut.31.5.526 Quigley, 2001, AGA technical review on nausea and vomiting, Gastroenterology, 120, 263, 10.1053/gast.2001.20516 Allen, 2004, Cannabinoid hyperemesis, Gut, 53, 1566, 10.1136/gut.2003.036350 Parkman, 2003, Electrogastrography, Neurogastroenterol Motil, 15, 89, 10.1046/j.1365-2982.2003.00396.x Forbes, 1995, Prophylactic therapy in cyclic vomiting syndrome, J Pediatr Gastroenterol Nutr, 21, S57, 10.1097/00005176-199501001-00016 Malcolm, 1997, Rumination syndrome, Mayo Clin Proc, 72, 646, 10.4065/72.7.646 Olden, 2001, Rumination syndrome, Curr Treat Options Gastroenterol, 4, 351, 10.1007/s11938-001-0061-z O’Brien, 1995, The rumination syndrome, Gastroenterology, 108, 1024, 10.1016/0016-5085(95)90199-X Thumshirn, 1998, Gastric mechanosensory and lower esophageal sphincter function in rumination syndrome, Am J Physiol, 275, G314 Johnson, 1987, Behavioral assessment and treatment of postprandial regurgitation, J Clin Gastroenterol, 9, 679, 10.1097/00004836-198712000-00013